1. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook
   Adhimoolam Karthikeyan et al, 2021, Pharmaceutics CrossRef
2. Animal models of inflammatory bowel disease: category and evaluation indexes
   Changlin Wen et al, 2023, Gastroenterology Report CrossRef
3. Evaluating the effects of curcumin nanomicelles on clinical outcome and cellular immune responses in critically ill sepsis patients: A randomized, double-blind, and placebo-controlled trial
   Arash Karimi et al, 2022, Frontiers in Nutrition CrossRef
4. The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
   Qingrong Li et al, 2024, Journal of Nanobiotechnology CrossRef
5. Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis
   Juntao Yin et al, 2022, Journal of Ethnopharmacology CrossRef
6. Tuning the Microstructures of Electrospray Multicore Alginate Microspheres for the Enhanced Delivery of Astaxanthin
   Hongliang Li et al, 2023, ACS Omega CrossRef
7. MicroRNA‐150‐5p is upregulated in the brain microvasculature during prenatal alcohol exposure and inhibits the angiogenic factor Vezf1
   Gabriela Perales et al, 2022, Alcoholism: Clinical and Experimental Research CrossRef
8. Review of the Effects and Mechanism of Curcumin in the Treatment of Inflammatory Bowel Disease
   Yuan Lin et al, 2022, Frontiers in Pharmacology CrossRef
9. Identification of OLA1 as a Novel Protein Target of Vitexin to Ameliorate Dextran Sulfate Sodium-Induced Colitis with Tissue Thermal Proteome Profiling
   Nan Li et al, 2023, Journal of Agricultural and Food Chemistry CrossRef
10. Therapeutic Potential of Curcumin in a Rat Model of Dextran Sulfate Sodium–Induced Ulcerative Colitis by Regulating the Balance of Treg/Th17 Cells
    Jing Guo et al, 2022, Inflammation CrossRef
11. Phytochemicals as regulators of Th17/Treg balance in inflammatory bowel diseases
    Yaoyao Chang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
12. Sensitization of GSH synthesis by curcumin curtails acrolein-induced alveolar epithelial apoptosis via Keap1 cysteine conjugation: A randomized controlled trial and experimental animal model of pneumonitis
    Eun Hee Jo et al, 2023, Journal of Advanced Research CrossRef
13. Shaoyao decoction alleviates TNBS-induced ulcerative colitis by decreasing inflammation and balancing the homeostasis of Th17/Treg cells
    Dongsheng Wu et al, 2023, BMC Complementary Medicine and Therapies CrossRef
14. Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
    Yuanming Yang et al, 2022, Frontiers in Pharmacology CrossRef
15. MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
    Lisa Kinget et al, 2021, Cancers CrossRef
16. Dissecting specific Wnt components governing osteogenic differentiation potential by human periodontal ligament stem cells through interleukin-6
    Medania Purwaningrum et al, 2023, Scientific Reports CrossRef
17. Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Preetha Iyengar et al, 2024, Nutrients CrossRef
18. Efficacy of oral consumption of curcumin/ for symptom improvement in inflammatory bowel disease: A systematic review of animal models and a meta-analysis of randomized clinical trials
    MARLA DE CERQUEIRA ALVES et al, 2022, BIOCELL CrossRef
19. Traditional Chinese Medicine Regulates Th17/Treg Balance in Treating Inflammatory Bowel Disease
    Fengjiao Xie et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
20. Curcumin alleviates experimental colitis in mice by suppressing necroptosis of intestinal epithelial cells
    Yuting Zhong et al, 2023, Frontiers in Pharmacology CrossRef